Bluesight for Controlled Substances featured in Quartz article about the role of tech in combating the opioid crisis

Jenny HarlettBlog, News

The nation is in the grip of a tragic opioid crisis, and drugs that are meant for hospital patients are finding their way into other hands. Controlled substance diversion in hospitals is one culprit that is receiving increasing scrutiny.

Quartz recently took a look at ways that hospitals can combat diversion among providers, including the role that technology can play.

The publication spoke to experts in the field, including Kit Check CEO Kevin MacDonald. Kevin talks about how Bluesight for Controlled Substances uses AI, machine learning, and meta data to pinpoint behaviors that can help to identify diverters.

Read the full article here.